Celastrol could modulate inflammation through inhibition of the COX-2 activity and markedly alleviated the clinical signs, synovial hyperplasia, and inflammatory cell infiltration of joints in a collagen-induced RA rat model, related to inhibition of NF-kappa B activation [47–49]. Here, PTGS2 is linked to rheumatoid arthritis.